ABSTRACT
I. Introduction .............................................................................................308 II. Molecular epidemiological studies of aflatoxin and human liver
cancer ........................................................................................................309 III. Aflatoxin exposure and HBV infection in children ..........................310 IV. Aflatoxin exposure and mutations in the
p53
tumor suppressor gene ........................................................................................................... 311
V. Biomarkers and liver cancer prevention.............................................314 VI. Summary ..................................................................................................316
